Mira Pharmaceuticals (MIRA) Other Non-Current Assets (2023)

Mira Pharmaceuticals (MIRA) posted Other Non-Current Assets of $3.5 million for Q4 2023, little changed sequentially from $3.5 million in Q3 2023.

Mira Pharmaceuticals (MIRA) Other Non-Current Assets (2023) Analysis & Trends

Mira Pharmaceuticals (MIRA) has 1 years of Other Non-Current Assets data on file, last reported at $3.5 million in Q4 2023.

Quarterly Other Non-Current Assets changed N/A year-over-year to $3.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3.5 million (changed N/A YoY) and the FY2023 annual result came in at $3.5 million, changed N/A from the prior year.
Other Non-Current Assets steadied at $3.5 million in Q4 2023 per MIRA's latest filing, from $3.5 million in the prior quarter.
The five-year high for Other Non-Current Assets was $3.5 million in Q2 2023, with the low at $3.5 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	7.23 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	14.11 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	10.54 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	19.81 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	12.76 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	4.55 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	9.83 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-	200.00 Mn
10	Mira Pharmaceuticals	22.51 Mn	11.48 Mn	-	-

Download Data